Business
Vivos Therapeutics Forms Clinical Advisory Board to Drive Further Growth of Next-Generation Obstructive Sleep Apnea Treatment Efforts
Internationally Recognized Medical and Dental Industry Veterans Will Work Closely with Vivos Management to Drive Further Commercial Success HIGHLANDS RANCH,
About this update from Vivos Therapeutics, Inc.
[{"type":"text","content":"Internationally Recognized Medical and Dental Industry Veterans Will Work Closely with Vivos Management to Drive Further Commercial Success\nHIGHLANDS RANCH, Colo., Jan. 29, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including obstructive sleep apnea (OSA), today announced that the Company has established a Clinical Advisory Board to further drive adoption and growth of its next-generation treatments for OSA, of which 1 billion people suffer from globally. Members of Vivos’ Clinical Advisory Board currently include: Clete A. Kushida, MD, PhD – Neurologist, sleep specialist, Stanford Sleep Medicine Center’s Division Chief and Medical Director, World Sleep Society’s founding PresidentEdward Zuckerberg, DDS – Nationally recognized key opinion leader in the advanced dentistry fieldMichael Gelb, DDS, MS – American Board of Orofacial Pain Diplomate, NYU College of Dentistry Clinical Professor, American Academy of Physiological Medicine and Dentistry Co-FounderManisha Witmans, MD, FAASM – Board-certified sleep specialist and pediatric pulmonologist, Associate Clinical Professor at the University of AlbertaTammarie Heit, DDS, MICCMO, RN – Completed mastership program at the International College of Craniomandibular Orthopedics, established private practice focused on craniofacial sleep medicine and dentistryJon Caulfield, DDS – American Sleep and Breathing Academy Diplomate; established private practice specializing in airway, sleep and TMJ disorders “In forming Vivos’ new Clinical Advisory Board, we sought out the world’s leading minds in the sleep medicine and dentistry fields,” said Kirk Huntsman, Vivos’ Chairman and Chief Executive Officer. “Each member holds the highest level of credentials and brings decades of combined experience to the table. They are charged with ensuring that our Vivos System technology remains at the forefront of treatment for patients continuing to suffer from sleep apnea across the U.S.” About Vivos Therapeutics, Inc. Vivos Therapeutics Inc. (NASDAQ: VVOS) is a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including obstructive s...